Anteris Technologies announced its Q3 2026 results highlighting progress in the global PARADIGM Trial for its DurAVR transcatheter heart valve, expanding enrollment across the US, Canada, Europe, and Australia. The company also began operations at a new Minnesota facility to scale production ahead of commercialization. Financially, Anteris reported $22.9 million in operating cash outflows driven by clinical and manufacturing activities. The PARADIGM Trial aims to compare DurAVR THV's safety and effectiveness against existing valves in about 1,000 patients, supporting future regulatory and commercial milestones.
Anteris Technologies' Q3 2026 results provide context for health sector activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Nov 11, 2026 04:52 WIB: Out of 150 priced US health-sector stocks, 49 rose and 100 fell today. Notable movers include ACADIA Pharmaceuticals Inc. (ACAD) with a price of USD 18.16 and a 10.06% increase, Crispr Therapeutics AG (CRSP) down 9.05% at USD 45.51, and Ionis Pharmaceuticals Inc. (IONS) down 8.87% at USD 28.25. Typical hold times range from 4 to 79 days, with Pluang order activity showing a strong buy interest in ACAD and heavy sell pressure in CRSP.
Cannabis Strategic Ventures has finalized its change of control with Scopien Technologies, an AI platform company, which now holds voting control through preferred stock. The company has appointed new leadership, including CEO Zameer Mulla, and plans...
Star Bulk Carriers Corp. has published its 2025 Environmental, Social and Governance (ESG) Report, its eighth annual report detailing the company's sustainability strategy, performance, and future objectives. The report, guided by the ESG Committee, ...
TELA Bio reported $19 million revenue in Q3 2026, down 8% year-over-year but with an 18% increase in international sales. The company reduced its operating loss by 21% sequentially and improved adjusted EBITDA loss by 55%, driven by a strategic cost ...
Auburn National Bancorporation, Inc. announced a quarterly cash dividend of $0.27 per share, payable on December 28, 2026, to shareholders recorded by December 10, 2026. The company is the parent of AuburnBank, an Alabama state-chartered bank with ab...
OpenTable's 2027 Quebec dining trends report shows a 9% increase in restaurant bookings, with 65% of Quebecers planning to dine out as much or more in 2027. Consumers prioritize value, local favorites, and meaningful experiences, often celebrating sm...
